SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,514,520 | +43668.5% | 1,094,000 | 0.0% | 1.20% | -49.7% |
Q2 2023 | $51,440 | +12.1% | 1,094,000 | 0.0% | 2.39% | +5.8% |
Q1 2023 | $45,904 | -99.9% | 1,094,000 | 0.0% | 2.26% | +2.5% |
Q4 2022 | $41,725,160 | -2.6% | 1,094,000 | 0.0% | 2.20% | -8.7% |
Q3 2022 | $42,841,000 | +21.2% | 1,094,000 | 0.0% | 2.41% | +7.6% |
Q2 2022 | $35,336,000 | -2.4% | 1,094,000 | 0.0% | 2.24% | +20.3% |
Q1 2022 | $36,211,000 | -22.2% | 1,094,000 | 0.0% | 1.86% | +2.9% |
Q4 2021 | $46,539,000 | -4.0% | 1,094,000 | 0.0% | 1.81% | +6.8% |
Q3 2021 | $48,475,000 | -22.0% | 1,094,000 | 0.0% | 1.69% | -22.8% |
Q2 2021 | $62,150,000 | -24.1% | 1,094,000 | 0.0% | 2.19% | -21.0% |
Q1 2021 | $81,886,000 | -13.5% | 1,094,000 | 0.0% | 2.78% | -8.7% |
Q4 2020 | $94,642,000 | +41.5% | 1,094,000 | 0.0% | 3.04% | +31.6% |
Q3 2020 | $66,865,000 | +47.0% | 1,094,000 | 0.0% | 2.31% | +15.6% |
Q2 2020 | $45,489,000 | +3.4% | 1,094,000 | -28.6% | 2.00% | -33.3% |
Q1 2020 | $44,014,000 | +74.2% | 1,532,510 | +337.9% | 3.00% | +109.9% |
Q4 2019 | $25,267,000 | – | 350,000 | – | 1.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
RA Capital Management | 455,173 | $74,972,000 | 6.27% |
Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |